Shares of Vitalhub Corp. (TSE:VHI – Get Free Report) have earned an average recommendation of “Buy” from the seven brokerages that are covering the company, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is C$13.14.
VHI has been the subject of a number of analyst reports. ATB Cormark Capital Markets decreased their price objective on Vitalhub from C$16.50 to C$15.00 and set an “outperform” rating for the company in a research note on Tuesday, March 10th. National Bank Financial cut their target price on Vitalhub from C$14.00 to C$11.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 27th. Finally, Raymond James Financial reduced their target price on Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating on the stock in a report on Tuesday, March 24th.
Vitalhub Price Performance
Vitalhub (TSE:VHI – Get Free Report) last announced its quarterly earnings data on Thursday, May 7th. The company reported C$0.04 earnings per share (EPS) for the quarter. The firm had revenue of C$31.91 million for the quarter. Vitalhub had a net margin of 6.13% and a return on equity of 2.98%. Equities research analysts anticipate that Vitalhub will post 0.2296467 earnings per share for the current year.
Insider Activity at Vitalhub
In other news, Director Anthony Pius Shen bought 7,000 shares of the business’s stock in a transaction on Monday, March 30th. The shares were bought at an average cost of C$7.11 per share, for a total transaction of C$49,770.00. Following the completion of the acquisition, the director owned 12,470 shares in the company, valued at approximately C$88,661.70. This trade represents a 127.97% increase in their position. Also, Director Steve Garrington sold 10,000 shares of Vitalhub stock in a transaction on Friday, June 5th. The stock was sold at an average price of C$7.17, for a total transaction of C$71,700.00. Following the transaction, the director directly owned 50,000 shares in the company, valued at approximately C$358,500. This represents a 16.67% decrease in their ownership of the stock. 18.57% of the stock is owned by company insiders.
About Vitalhub
Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.
Featured Stories
- Five stocks we like better than Vitalhub
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
